Theta Burst Stimulation for Motor Recovery

Launched by NATIONAL TAIWAN UNIVERSITY HOSPITAL · Nov 6, 2022

Keywords

ClinConnect Summary

This clinical trial is studying a treatment called repetitive transcranial magnetic stimulation (rTMS) to help improve motor recovery in patients who have had a stroke. The researchers want to find out how different doses of a specific type of rTMS, known as intermittent Theta Burst Stimulation (iTBS), can help patients regain movement and improve the brain's ability to control muscles after a stroke.

To participate in this trial, individuals must be at least 20 years old and have experienced a stroke within the last three months that affects one side of their body. They should have some difficulty with muscle strength in their upper limb, but they should be able to sit for at least 15 minutes. However, people with certain medical conditions, like previous strokes, severe neurological diseases, or those who are pregnant, will not be eligible. Participants can expect to receive treatment using this non-invasive technology, which aims to enhance their recovery process. This study is currently looking for volunteers, and all genders are welcome to apply.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1.Unilateral ischemic or hemorrhagic stroke
• • 2.Stroke within 3 months
• • 3.Medical Research Council Scale for Muscle Strength in upper limb ≤ 3
• • 4.No previous stroke, seizure, dementia, Parkinson's disease or other degenerative neurological diseases.
• • 5.Patient could sit over 15 minutes
• • 6.Age over 20
• Exclusion Criteria:
• • 1.Previous stroke, traumatic brain injury, brain tumor
• • 2.With central nervous system disease (spinal cord injury, Parkinson's disease)
• • 3.Any contraindication to rTMS (seizure, alcoholism, metal implant, pacemaker)
• • 4.Patients unable to cooperate the treatment
• • 5.Pregnancy
• • 6.Depression